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In mammals, the transcription factor SRY, encoded
by the Y chromosome, is normally responsible for
triggering the indifferent gonads to develop as testes
rather than ovaries. However, testis differentiation
can occur in its absence. Here we demonstrate in
the mouse that a single factor, the forkhead tran-
scriptional regulator FOXL2, is required to prevent
transdifferentiation of an adult ovary to a testis.
Inducible deletion of Foxl2 in adult ovarian follicles
leads to immediate upregulation of testis-specific
genes including the critical SRY target gene Sox9.
Concordantly, reprogramming of granulosa and
theca cell lineages into Sertoli-like and Leydig-like
cell lineages occurs with testosterone levels compa-
rable to those of normal XY male littermates. Our
results show that maintenance of the ovarian pheno-
type is an active process throughout life. They might
also have important medical implications for the
understanding and treatment of some disorders of
sexual development in children and premature
menopause in women.
Foravideosummaryof thisarticle, see thePaperFlick
file with the Supplemental Data available online.
INTRODUCTION
Sex determination in vertebrate species exhibits a broad variety
of mechanisms based either on genotype or environmental
factors (Barske and Capel, 2008; Guiguen et al., 2009). In almost
all mammals the heterogametic sex is male, propagated by
the inheritance of a Y chromosome. The discovery of a single
gene, Sry, on the Y chromosome and its subsequent functional
analysis has demonstrated that SRY is necessary and sufficient
to initiate testicular development (Koopman et al., 1991; Sinclair1130 Cell 139, 1130–1142, December 11, 2009 ª2009 Elsevier Inc.et al., 1990). SRY stands at the top of a genetic cascade that
directs the differentiation of the bipotential gonad toward a testis
fate through activation of its direct target gene Sox9 (Dinapoli
and Capel, 2008; Sekido and Lovell-Badge, 2009). When misex-
pressed in XX mice or humans, SOX9, which belongs to the
same family of HMG-box transcription factors as SRY but is
encoded by an autosomal gene, is also able to induce testis
formation (Bishop et al., 2000; Vidal et al., 2001). In the absence
of SRY or SOX9 function the bipotential gonad develops as an
ovary (Barrionuevo et al., 2006; Chaboissier et al., 2004). Subse-
quent to gonadal differentiation, the different types and levels
of hormones produced by the testes and ovaries dictate the
differentiation of most secondary sexual characteristics (Wilhelm
and Koopman, 2006), others being dependent on the direct
action of Y- and X-linked genes (Arnold, 2009).
XX male sex reversal could result from gain of function muta-
tions (GOF) in genes that promote testis development or loss of
function mutations (LOF) in genes that oppose them or actively
promote ovary development. In humans, most XX males have
a functional SRY gene due to abnormal X-Y interchange during
male meiosis, however some rare cases lack SRY (Pannetier
et al., 2004). Duplications affecting SOX9 can be responsible
(Huang et al., 1999), a situation that reflects experimental
manipulation of mice where complete XX sex reversal can be
achieved by ectopic expression in the developing XX gonad
of SRY or SOX9, or of other SOX proteins that mimic these
(Bishop et al., 2000; Koopman et al., 1991; Vidal et al., 2001).
XX gonads can also show testicular development in culture
when treated with FGF9 or prostaglandin D2, both of which
are involved in positive autoregulatory loops required to main-
tain high levels of SOX9 expression or activity (Kim et al.,
2006; Moniot et al., 2009; Wilhelm et al., 2007). The common
denominator in all these cases of primary XX male sex reversal
is the activation of SOX9 in the indifferent gonad. In the mouse,
SRY has to function within a narrow time window to upregulate
Sox9 otherwise the gene is repressed and ovaries develop
(Hiramatsu et al., 2009). Candidates for genes that oppose
the male pathway include Nr0b1 (also called Dax1), Wnt4,
Rspo1, and Foxl2.
DAX1 is thought to recruit corepressors when it is complexed
with steroidogenic factor 1 (SF1 or Nr5a1). The latter is amember
of the nuclear receptor superfamily required for gonadal devel-
opment in both sexes, but with an especially important role in
testis development as it contributes to the activation of male
pathway genes, including Sry and Sox9 (Sekido and Lovell-
Badge, 2008). Over-expression of DAX1 can lead to XY female
development, however, LOF mutations have not revealed
a role in ovaries (Bouma et al., 2005; Swain et al., 1998). WNT4
and RSPO1 both serve to stabilize b-catenin, and ectopic
expression of a stable form of b-catenin in XY gonads can lead
to ovary development (Maatouk et al., 2008). However, LOF
mutations of Wnt4 and Rspo1 in the mouse lead to only partial
XX male sex reversal, suggesting that additional factors still
ensure that SOX9 activity is repressed (Chassot et al., 2008a;
Jeays-Ward et al., 2003; Vainio et al., 1999). Cases of human
XX male development have been attributed to homozygous
null mutations in RSPO1 (Parma et al., 2006), or with LOF muta-
tions inWNT4 associated with SERKAL syndrome (Mandel et al.,
2008), which might suggest that human sex determination is
more sensitive than mouse to levels of b-catenin. However,
care has to be taken in interpreting gonadal phenotypes after
birth by which time ovotestes may have resolved into testes, or
other secondary changes may have occurred. In Wnt4 mutant
XX gonads, Sertoli-like cells begin to appear at late fetal stages
and Leydig-like cells increase in number (Vainio et al., 1999). This
was associated with dysgenesis and loss of oocytes, and was
thought to reflect other circumstances where Sertoli and Ley-
dig-like cells appear in an XX gonad; for example in Freemartins,
or when fetal ovaries are grafted to the kidney capsule, in adult
XX mice carrying mutations in both estrogen receptors or in
the aromatase gene (Cyp19a1), or in Sertoli/Leydig tumors in
postmenopausal women (Couse et al., 1999; Guiguen et al.,
2009; Sekido and Lovell-Badge, 2009). However, in none of
these cases has it been shown whether the appearance of
Sertoli- and Leydig-like cells in an ovary could be due to transdif-
ferentiation from granulosa and theca cells as suggested by
Burgoyne et al. (1988), or differentiation from populations of
immature precursor cells.
FOXL2 mutations in the human germline lead to the autosomal
dominant blepharophimosis/ptosis/epicanthus inversus syn-
drome (BPES) associated with premature ovarian failure in
females (Crisponi et al., 2001). Furthermore, deregulated FoxL2
expression has been described in the goat polled intersex
syndrome (PIS) where XX male sex reversal occurs (Pailhoux
et al., 2001). Similarly, global deletion of Foxl2 (Foxl2/) during
development in mice leads to ovary dysgenesis and infertility
(Schmidt et al., 2004; Uda et al., 2004). Although the Foxl2/
mutant phenotype becomes apparent only late in fetal develop-
ment with derepression of some testis specific genes, it could
reflect the much earlier loss of Foxl2 expression, which is ovary-
specific from E12.5 (Ottolenghi et al., 2005; Schmidt et al., 2004).
Understanding the plasticity of an adult ovary at the cellular
level and the extent to which ‘‘terminally’’ differentiated gonadal
cell types can switch to a new fate would provide molecular
insight into not just the maintenance of the differentiated state
in the mammalian gonad, but perhaps also well known postnatal
sex conversion phenomena in lower vertebrates.Here, we show that upon conditional loss of Foxl2 in the adult
ovary the two major female-specific somatic cell lineages switch
their cell fate revealing a rare example of true adult lineage
reprogramming in vivo. While granulosa cells, which support
oocytes, are reprogrammed into testis-specific Sertoli-like cells,
the steroidogenic theca cell lineage upregulates 17-beta hydroxy-
steroid dehydrogenase type 3 (Hsd17b3), the rate-limiting
enzyme in testosterone biosynthesis resulting in male-like levels
of testosterone in the blood. Using a combination of genetically
based oocyte-ablation experiments we demonstrate that this
reprogramming is cell autonomous and oocyte-independent.
We show that FOXL2 represses the testis differentiation program
mainly through repression of Sox9-regulatory sequences that
are required for its testis-specific expression. We extend our
analysis by demonstrating that FOXL2 and estrogen receptor
(ESR1) cooperate in Sox9 repression in vivo, consequently
providing a mechanism by which loss of estrogen signaling
can lead to gonadal sex reversal.
RESULTS
Somatic Ovary-to-Testis Transdifferentiation upon
Conditional Deletion of Foxl2
To determine FOXL2 function during folliculogenesis in sexually
mature female mice we created a conditional allele, flanking the
single Foxl2 coding exon with loxP sites. Animals homozygous
for this are referred to as Foxl2f/f (Figure S1).We also took advan-
tage of a R26CreERT2 line that allows ubiquitous induction of
Cre recombinase activity upon tamoxifen (TM) administration.
This gave recombination efficiencies greater than 95% in adult
ovaries when crossed to an R26lacZ reporter strain (data not
shown). For conditional deletion of Foxl2, 8-week old Foxl2f/f
or R26CreERT2;Foxl2f/f female mice were treated for 5 days
with TM. Histological examination 3 weeks later unexpectedly
revealed gonadal sex reversal in XX R26CreERT2;Foxl2f/f
(‘‘conditional mutant’’) mice (Figure 1A). Structural changes
affected nearly the whole gonad, where the typical follicular
structure of the ovary now resembled in appearance the seminif-
erous tubules of the testis. Some degenerating oocytes were
still present whereas in most tubule-like structures germ cells
appeared to be lost. Instead of granulosa cells, cells with all
the morphological characteristics of testicular Sertoli cells
were present. These displayed a prominent basal lamina, tripar-
tite nucleoli and numerous veil-like cytoplasmatic extensions
pointing toward the lumen (Figure 1A). To obtain a global view
of the extent of lineage reprogramming, we performed genome-
wide gene expression analysis of wild-type ovaries, reprog-
rammed sex-reversed ovaries and testes. This revealed a large
gene set upregulated and expressed in common between
reprogrammed sex-reversed gonads and testes, including
well-characterized Sertoli and Leydig cell markers. This substan-
tiated the morphologically observed cell type switch at the
molecular level (Figures 1B–1D and Table S1 available online).
Foxl2 mRNA was no longer detectable in conditional mutant
XX gonads (Figure S2). Consistent with the mRNA profiling,
in situ hybridization studies demonstrated robust expression of
Sertoli cell markers and genes involved in testis determinationCell 139, 1130–1142, December 11, 2009 ª2009 Elsevier Inc. 1131
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Figure 1. Postnatal Gonadal Sex Reversal in XX Foxl2 Conditional Mutant Mice
(A) PAS staining showing morphology of XX Foxl2f/f (control) and XX R26CreERT2;Foxl2f/f mutant gonads three weeks after TM administration. Left panel: wild-
type, right panel: mutant at different magnifications. Note cytoplasmic extensions (asterisk), tripartite nucleoli (white arrow) and prominent basal laminae (black
arrow) in mutant structures, which are features of testicular Sertoli cells.
(B–D) Genome wide expression profiling of XX Foxl2f/f (control) and XX R26CreERT2;Foxl2f/f mutant gonads three weeks after TM administration. (B) Heat map of
the 200 genes that have the highest fold change out of the 915 genes that are upregulated at least 1.8-fold in XX R26CreERT2;Foxl2f/f mutant gonads after TM
administration (Colors red and green representing absolute expression levels). (C) Zoom in on a set of particular important genes selected out of the 915 upre-
gulated ones. (D) Heat map showing the 200 genes that are at least 1.8-fold upregulated in both XX R26CreERT2;Foxl2f/f mutant gonads and testis compared to
ovaries (for gene names, see Table S1).including Gata1, Tif2, Dax1, Dhh, Dmrt1, and notably Sox9
(Figure S2).
Although Foxl2f/f control ovaries were normal after TM admin-
istration, the phenotype seen in the conditional Foxl2 deletion
experiment could result from a cooperative effect between
Foxl2 loss and a context-dependent antagonistic estrogen
activity of TM. To rule out this possibility we used a noninducible
Cre-line, in which regulatory sequences from the a-glycoprotein
subunit (aGSU) gene drive the expression ofCre in the ovary only
after sexual maturation. aGsuCre;Foxl2f/f mice have the same
gonadal phenotype (Figure S3), directly demonstrating that dele-
tion of Foxl2 alone is sufficient to cause postnatal sex reversal in
the XX gonad.
Cell Autonomous Reprogramming of Granulosa
into Sertoli-Like Cells
The short time frame of 3 weeks between TM administration and
appearance of the somatic sex-reversed phenotype suggested
transdifferentiation of granulosa into Sertoli-like cells, but to1132 Cell 139, 1130–1142, December 11, 2009 ª2009 Elsevier Inc.rule out any developmental and/or hormonal phenomena we
examined when the molecular changes first occurred. Whereas
2 days after the start of TM administration FOXL2 was still
detected by immunohistochemistry, a day later FOXL2 was
absent from XX R26CreERT2;Foxl2f/f but not control gonads
(Figure 2A and data not shown). In contrast SOX9 immunostain-
ing first appeared 4 days after the start of TM administration in
the former. Thus for a period of about 1 day neither FOXL2 nor
SOX9 was detectable by immunohistochemistry suggesting
that high expression levels of both factors aremutually exclusive.
SOX9 expression started randomly within follicles where it was
often first detected in mural but not in cumulus granulosa cells
and thus spatially divided from the oocyte (Figure 2A). One
week after the start of TM administration SOX9 was expressed
in all cells in a typical granulosa cell location, but many had
already started to transdifferentiate into Sertoli-like cells despite
the presence of an oocyte (Figure 2B). These results strongly
suggest that granulosa cells undergo cell autonomous reprog-
ramming into Sertoli-like cells upon loss of Foxl2. In contrast
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Figure 2. Time-Course Analysis of XX R26CreERT2;Foxl2f/f Gonads
after Tamoxifen Administration
(A) FOXL2 and SOX9 immunostaining on ovarian sections of XX R26CreERT2;
Foxl2f/f gonads 2, 3, and 4 days after start of TM administration. In half of the
follicles SOX9 expression is first seen in mural but not cumulus granulosa cells
and thus spatially divided from the oocyte.
(B) TUNEL staining on conditional mutant XX gonads one week after TM treat-
ment, showing apoptotic nuclei (brown) in follicles which did not show signs of
transdifferentiation, but not follicles that have started to transdifferentiate into
Sertoli-like cells as evident by the appearance of the characteristic veil-like
cytoplasmatic extensions of Sertoli cells (see inset).
(C) PAS staining of XX R26CreERT2;Foxl2f/f gonads 6 months after an one-
week TMadministration showing grossmorphology. Note that Sertoli-like cells
are still present in the mutant XX gonads.to granulosa cells which undergo programmed cell death
(apoptosis) at the end of a follicle life cycle, major apoptosis
is normally not seen in Sertoli cells. Consistent with this, the
Sertoli-like cells in XX conditional mutant gonads do not undergo
apoptosis and were still present after 6 months (Figures 2B and
2C). Together these findings further support the notion that true
lineage reprogramming has occurred, resulting in a stable cell
type conversion.
Transdifferentiation of Granulosa Cells Is Independent
of Oocyte Function
It has been proposed on the basis of indirect evidence that
oocytes are required to maintain granulosa cell fate, and that in
their absence the latter can transdifferentiate into Sertoli-like
cells (Burgoyne et al., 1988; Guigon and Magre, 2006; McLaren,
1991). We addressed this possibility by taking advantage of
a mouse strain that expresses Cre under the control of Gdf9
regulatory sequences exclusively in oocytes of postnatal
ovaries. First, we generated Gdf9Cre;Foxl2f/f mice which were
fully fertile demonstrating that FOXL2 does not play a role in
oogenesis (data not shown). Next we crossed Gdf9Cre mice
with a R26DTA mouse line in which Diphtheria toxin expression
is activated upon Cre expression resulting in cell ablation.
Gdf9Cre;R26DTA mice were viable and analysis of ovaries
from 8-week old females demonstrated a complete absence
of oocytes (Figure 3A), yet FOXL2 was still expressed and not
SOX9 (Figure 3B). To substantiate this finding further, we
compared a set of informative genes by quantitative RT-PCR
in 8-week-old wild-type, Gdf9Cre;R26DTA (oocyte-depleted)
and conditional mutant ovaries. Unlike the latter, the oocyte-
depleted ovaries showed no significant deregulation of Sox9,
Foxl2, Dmrt1, HSD17b3, testatin (Cst9) or 17-beta hydroxyste-
roid dehydrogenase type 1 (Hsd17b1), which converts estrone
into estradiol (Figure 3C and data not shown). Finally, we ablated
oocytes in 8-week old sexually mature female mice in case
this had different consequences from deleting oocytes during
sexual maturation. In mice, only cells that express the human
Diphtheria toxin receptor (DTR) are susceptible to cell ablation
upon Diphtheria toxin (DT) administration. We therefore gener-
ated Gdf9Cre;R26iDTR animals and compared their ovaries
with those of control R26iDTR mice 9 days after DT administra-
tion. This is when follicles activated at the time of DT administra-
tion should have reached an antral stage (Hoage and Cameron,
1976) and by when ‘granulosa’ cells in XX R26CreERT2;Foxl2f/f
gonads express SOX9 after TM administration. As expected, in
control R26iDTR ovaries, TUNEL assays revealed apoptosis in
atretic but not preantral follicles. In contrast, both oocytes and
surrounding granulosa cells underwent apoptosis in preantral
follicles of Gdf9Cre;R26iDTR ovaries with no SOX9 expression
detectable (Figure 3D and data not shown). Taken together these
experiments demonstrate that granulosa cells become reprog-
rammed into Sertoli-like cells in XX R26CreERT2;Foxl2f/f gonads
upon TM administration in a cell-autonomous way. Moreover,
although consistent with oocyte health being essential for follicle
growth (Eppig, 2001), our findings challenge a long-standing
hypothesis in the field that oocytes are directly required to main-
tain somatic cell identity during ovarian development (Guigon
and Magre, 2006; McLaren, 1991).Cell 139, 1130–1142, December 11, 2009 ª2009 Elsevier Inc. 1133
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Figure 3. Diphteria Toxin-Mediated Oocyte Ablation in Adult Ovaries
(A and B) PAS, FOXL2 and SOX9 immunostaining on ovarian sections of 8-week old Gdf9Cre;R26DTA and control XX gonads. Despite the absence of oocytes in
Gdf9Cre;R26DTAovaries theremainingsomaticcellsstill expressFOXL2butnotSOX9.Consistentwith the lackofSOX9,notripartitenucleoliareobserved inthesecells.
(C) No significant change in the expression levels of representative genes by qRT-PCR is detected in Gdf9Cre;R26DTA in contrast to XX R26CreERT2;Foxl2f/f mutant
ovaries. The data are represented as mean ± SD (*p < 0.001).
(D)Detection of apoptosis by TUNELstaining. Positive TUNELstaining inatretic butnot preantral follicles is seen incontrol ovaries. In contrastpositive TUNELstaining is
observed in oocytes and surrounding granulosa cells (black arrows) in different preantral stage follicles of Gdf9Cre;R26iDTR ovaries. Representative pictures from two
different ovaries 9 days after the start of DT administration are shown.1134 Cell 139, 1130–1142, December 11, 2009 ª2009 Elsevier Inc.
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Figure 4. XX R26CreERT2;Foxl2f/f Gonadal Sex-Reversed Mutant
Mice Have Testosterone Levels Similar to Wild-Type XY Males
(A) In situ hybridization on XX control and XX sex-reversed gonads and control
testis showing ectopic expression of the testosterone-producing enzyme
HSD17B3 in cells surrounding Sertoli-like cells of R26CreERT2;Foxl2f/f sex
reversed gonads, in a pattern similar to that seen in normal testicular Leydig
cells. White signal, antisense probe; blue staining, nuclei.Appearance of Testosterone Producing Leydig-Like
Cells upon Loss of Foxl2
It has been suggested that the supporting cell lineages of the
testis and ovary arise from a common precursor during develop-
ment (Albrecht and Eicher, 2001). In contrast, the origin of the
steroidogenic lineages is less clear. Adult Leydig and theca cells
are both thought to be recruited from surrounding progenitor
populations after birth (Haider, 2004; Skinner, 2005). To ask
whether FOXL2-positive gonadal precursor cells give rise to
theca cells we generated a Cre replacement allele of the Foxl2
locus termed Foxl2Cre (Figure S1). Using this allele in combination
with the R26lacZ reporter we could demonstrate that Foxl2
expressing cells indeed give rise to the theca cell lineage
(Figure S4). To further facilitate the analysis of FOXL2 function,
we generated a mouse line (Foxl2HAFoxl2) in which the endoge-
nousFoxl2 locus ismodified so that FOXL2 isN-terminally tagged
with a HA-epitope. These retain full FOXL2 activity as homozy-
gous Foxl2HAFoxl2/HAFoxl2 female mice are fertile (Figure S1 and
data not shown). Immunohistochemical detection of HA-tagged
FOXL2 protein demonstrated maintenance of FOXL2 expression
in theca cells of the adult ovary (Figure S4). Desert hedgehog
(DHH), which has been shown to be required for specification
of Leydig cells in the fetal testis (Yao et al., 2002), is upregulated
in XX Foxl2-deleted sex-reversed gonads as were many Leydig
cell markers including Hsd17b3 (Figure S2). Hsd17b3 was found
to be expressed in sex-reversed gonads in a similar pattern
to adult testis (Figure 4A). We therefore asked if the putative
Leydig-like cells produced circulating testosterone. Indeed
similar levels were found in XX gonadal sex-reversed mice and
wild-type XY littermates, with a direct correlation with expression
levels of Hsd17b3 (Figures 4A and 4B). Whether loss of Foxl2
within theca cells is sufficient on its own to switch them into
Leydig-like cells or rather makes them permissive for paracrine
inducing molecules, such as DHH or PDGF from the Sertoli-like
cells remains to be investigated (Brennan et al., 2003; Schmahl
et al., 2008). However, the differentiation of Leydig cells in
aGSUCre:Foxl2f/f XX mice, where Cre should not be active in
theca cells, implies that such paracrine factors are sufficient.
Repression of TESCO by FOXL2 in the Adult Ovary
The rapid upregulation ofSox9 expression suggested direct tran-
scriptional repression of Sox9 by FOXL2 in the ovary. Recently,
the cis-regulatory element for testis-specific Sox9 expression,
referred to as TESCO, has been identified (Sekido and Lovell-
Badge, 2008). Consistent with the activity of a TESCO-ECFP
transgene during embryonic development (Sekido and Lovell-
Badge, 2008), ECFP was detected in Sertoli cells of the adult
testis but not in granulosa cells of the adult ovary (Figure 5A).
To ask whether TESCO is activated upon loss of Foxl2 in adult
(B) PAS staining of control ovaries and testes, and XX sex-reversed gonads,
showing the morphological similarity between mutant ‘‘follicles’’ and seminif-
erous tubules. Note that the levels of serum testosterone, as well as the levels
of Hsd17b3 expression correlate with the number of tubule-like structures in
XX R26CreERT2;Foxl2f/f sex-reversed gonads.
(C) Serum testosterone levels (ng/ml) as measured by RIA of control Foxl2f/f XX
females (n = 6), XY males (n = 6) and XX R26CreERT2;Foxl2f/f gonadal sex-
reversed mutant mice (n = 12).Cell 139, 1130–1142, December 11, 2009 ª2009 Elsevier Inc. 1135
ovaries, the TESCO-ECFP reporter was crossed into the
R26CreERT2;Foxl2f/f genetic background. We observed strong
TESCO activation after tamoxifen-induced Foxl2 deletion sug-
gesting that FOXL2 may regulate TESCO in vivo (Figure 5B).
Examination of the TESCO sequence indeed revealed predicted
forkhead (FOX) binding sites (Figure S5). We therefore asked
if FOXL2 binds to this Sox9 cis-regulatory element in vivo. To
perform FOXL2 chromatin immunoprecipitation (ChIP) assays
from adult ovaries we took advantage of our Foxl2HAFoxl2 mouse
line. We used an HA-epitope specific antibody on DNA-protein
cross-linked material isolated from 8-week old Foxl2HAFoxl2 and
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Figure 5. Testis-Specific Enhancer of Sox9,
TESCO, Is Directly Repressed by FOXL2
(A) TESCO drives expression of an ECFP reporter
in the adult testis but not ovary. ECFP expression
is detected by immunohistochemistry with an
a-GFP antibody (note unspecific staining in
oocytes and some interstital cells of the ovary).
However, upon Foxl2 deletion, TESCO activity is
strongly induced in granulosa cells within one
week after the start of TM administration in ovaries
of XX R26CreERT2;Foxl2f/f mice.
(B) Schematic drawing of the TESCO-Sox9
genomic region indicating the primer pairs used
for ChIP analysis (see Figure S5 for exact positions
of binding sites).
(C) FOXL2 binds to TESCO sequences in vivo as
demonstrated by ChIP comparing the relative
enrichment obtained through a HA-epitope
specific antibody from wild-type FOXL2 and
HAFOXL2 ovaries.
(D) FOXL2 can repress TESCO driven luciferase
reporters in transient transfection assays. Dose
dependent repression of TESCO is shown for
FOXL2 with SF1 and SOX9.
Error bars show standard deviations of three
biological replicates performed in triplicate,
asterisks denote (*p < 0.05, **p < 0.01, ***p <
0.001).
wild-type ovaries and directly compared
the relative enrichment obtained for
specific DNA loci between the two
samples.With Foxl2HAFoxl2 ovarieswe ob-
tained a 6-fold enrichment using primers
that spanned TESCO and a 7-fold enrich-
ment around the Sox9 transcription start
site compared to wild-type ovaries
(Figure 5C), consistent with the looping
model of distant regulatory elements in
transcriptional initiation. In contrast, no
relative enrichment was seen for other
Sox9 genomic regions that served as
controls. To further demonstrate that
FOXL2 can negatively modulate TESCO,
we performed transient transfection
reporter assays employing the same
DNA sequences. As shown in Figure 5D,
FOXL2 attenuated activation of the
TESCO-regulatory element by SF1, SOX9/SF1 or SRY/SF1
in vitro.
FOXL2 and ESR1 Cooperatively Suppress Granulosa
Cell Reprogramming
A similar phenotype with appearance of Sertoli-like cells ex-
pressing Sox9 in postnatal ovaries has been described in Esr1/
Esr2 double mutant XX mice (Couse et al., 1999). Furthermore,
forkhead transcriptional regulators have been shown to be
essential for estrogen receptor DNA binding in other systems
such as breast cancer cell lines (Carroll et al., 2005).1136 Cell 139, 1130–1142, December 11, 2009 ª2009 Elsevier Inc.
Interestingly, nuclear hormone receptor DNA binding motifs are
present in the TESCO sequence, raising the possibility that
estrogen receptors are also binding to this Sox9 regulatory
element in the adult ovary (Figure S5). As with FOXL2, we
observed a 5- to 10-fold enrichment of ESR1-occupied
sequences in ChIP assays over mock control (Figure 6A).
Although ESR1 was not able to repress the TESCO regulatory
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Figure 6. FOXL2 and ESR1 Together Regu-
late TESCO Activity
(A) ChIP analysis demonstrates ESR1 binding to
TESCO sequences in adult ovaries. Error bars
show standard error of the mean, from three
biological replicates.
(B) FOXL2 and ESR1 synergize in repressing
a TESCO driving luciferase reporter, which is acti-
vated by SOX9 and SF1 in transient transfection
assays in a DNA binding dependent manner, while
the synergistic repression is abolished when both
FOX and ERE binding sites are mutated. The data
are represented as mean ± SD (*p < 0.001).
(C) Transgenic founder analysis of mutated
TESCO-ECFP reporters. The number of trans-
genic founders analyzed for each construct is indi-
cated. Expression of the TESCO-ECFP transgenic
reporter is only seen in follicles upon mutation of
FOX and ERE simultaneously (see Figure S6).
Immunostaining for ECFP in ovarian follicles
from two different independent TESCOFOX/EREmut-
ECFP lines are shown next to a TESCO-ECFP line.
(D) Coimmunoprecipitation of Flag-tagged FOXL2
and V5-tagged nuclear hormone receptors from
HEK293 cells demonstrating a strong physical
interaction between FOXL2 and ESR1 or ESR2.
Under the same conditions glucocorticoid recep-
tor (GR) does not interact demonstrating the spec-
ificity of the FOXL2/ESR1/2 interaction.
(E) PAS staining of gonads from 8-week old
Foxl2Cre/+;Esr1f/f XX mice demonstrating the pres-
ence of Sertoli-like cells. This phenotype is not
seen in ovaries of Foxl2Cre/+;Esr1wt/f mice (data
not shown) and has also not been reported in
Esr1 null mutant ovaries (Couse et al., 1999).
SOX9 immunostaining on sections from another
Foxl2Cre/+;Esr1f/f XX gonad demonstrating the
expression of SOX9 in cells that have amorpholog-
ical Sertoli-like appearance.
element on its own, together with
FOXL2 synergistic repression was
observed in transient transfection assays
(Figure 6B). To show that the repression
of the TESCO regulatory element by
FOXL2 and ESR1 is mediated through
the putative forkhead and estrogen
receptor (ERE) binding sites within
TESCO we mutated the corresponding
sequences (Figure S6). Mutation of all
putative forkhead binding sites in TESCO
did not lead to a loss of repression in tran-
sient transfection assays. This could be
due to the presence of additional forkhead sites in TESCO to
which FOXL2 can bind. Indeed, a recent study claims that, in
addition to the ‘classical’ forkhead site, FOXL2 can bind a DNA
binding motif that resembles two estrogen receptor DNA binding
half-sites and the consensus binding site for SF1 (Benayoun
et al., 2008; Carroll et al., 2005). Consistent with this finding
the combined mutation of the putative ‘classical’ forkhead andCell 139, 1130–1142, December 11, 2009 ª2009 Elsevier Inc. 1137
estrogen receptor binding sites (which may in addition be bound
by FOXL2) in TESCO abolished the observed synergistic repres-
sive effect of ESR1 together with FOXL2 in our transient transfec-
tion assay (Figure 6B).
Although in vitro assays are informative, DNA regulatory
elements may be under additional constraints when integrated
into the genome. We speculated that relief of repression of
TESCO may lead to the expression of the mutated TESCO
elements in the adult ovary. This would still require the presence
of factors able to activate the element, and it is notable that
both SF1 and SOX8, a close homolog of SOX9 are present
in the adult ovary albeit at low concentrations (Salmon et al.,
2005). We therefore analyzed TESCO elements harboring
different sequence mutations in transgenic animals to find that
neither mutation of the forkhead sites alone nor mutation of
the putative estrogen receptor binding sites alone, leads to
derepression in adult ovaries. However when both types of
site were simultaneously mutated, derepression of the TESCO
element was observed during folliculogenesis (Figure 6C).
Although concordant with our in vitro cotransfection results,
the lack of derepression of the TESCO element upon mutation
of all putative forkhead binding sites in vivo could be due to
the presence of alternative sites, as discussed above, to func-
tional redundancy between FOXL2 and ESR1 (although Foxl2
mutations are far more severe than even Esr1/2 double null
mutations), or to the ability of FOXL2 and ESR1 to recruit each
other via protein-protein interaction in the absence of the
other’s DNA binding site. We therefore tested if FOXL2 and
ESR1/ESR2 can interact at the protein level. Indeed, coimmuno-
precipitation experiments from HEK293 cells expressing FLAG-
tagged FOXL2 and V5-tagged ESR1 or ESR2 demonstrated
a strong protein-protein interaction between these proteins in
contrast to glucocorticoid receptor, which does not show any
significant interaction with FOXL2 under the same conditions
(Figure 6D). Finally, we tested the observed interaction of
FOXL2 and estrogen receptors in vivo by generating female
mice with the genotype Foxl2Cre/+;Esr1fl/fl in which all granulosa
cells, but not oocytes have lost ESR1 and one Foxl2 allele
utilizing a floxed Esr1 allele. The appearance of Sertoli-like cells
expressing SOX9 in 8-week old ovaries of Foxl2Cre/+;Esr1fl/fl
mice, which is neither observed in Foxl2Cre/+ nor in Esr1/
mice, further supports the suggested cooperation of FOXL2
with estrogen receptors in Sox9 repression in vivo (Figure 6E
and data not shown).
DISCUSSION
Although sex determination is essential for successful repro-
duction of most species within the animal kingdom the under-
lying molecular mechanisms are marginally conserved from
Drosophila to man. At least vertebrates have a common set
of transcriptional regulators known to be involved, including
DAX1, DMRT1, SF1, SOX9, FOXL2 and WT1, as well as
some signaling molecules such as FGF9 and WNT4 (Barske
and Capel, 2008; Guiguen et al., 2009; Shoemaker and Crews,
2009). However, their molecular interplay and epistatic relation-
ships seem highly variable and are still far from being under-
stood.1138 Cell 139, 1130–1142, December 11, 2009 ª2009 Elsevier Inc.In mammals, SRY is the dominant switch initiating testes
development, and it does so by directly upregulating the expres-
sion of Sox9 in cells of the supporting cell lineage (Sekido and
Lovell-Badge, 2008). Once above a critical threshold, SOX9
initiates several positive autoregulatory loops that maintain the
high levels of SOX9 expression and activity that are necessary
for Sertoli cell differentiation and function. These ‘‘feedforward’’
mechanisms, which make continued expression of SRY unnec-
essary, include SOX9 binding together with SF1 to its own regu-
latory region, as well as the upregulation of Fgf9 and prosta-
glandin D synthase (Ptgds), each of which make extracellular
signaling molecules that act back on early Sertoli cells (Kim
et al., 2006; Wilhelm et al., 2007). The maintenance of high levels
of SOX9 and subsequent Sertoli cell differentiation and testis
development can be overridden by manipulating WNT pathway
activation through overexpression of a stable form of b-catenin
in XY gonads (Maatouk et al., 2008). This finding has its concep-
tual counterpart in the XX gonad where loss of either the WNT
pathway activator R-Spondin or Wnt4 can lead to Sox9 upregu-
lation and XX male sex reversal, albeit with weak or partial
phenotypes (Chassot et al., 2008b; Tomizuka et al., 2008; Vainio
et al., 1999). Misexpression of Sox9 itself can give robust XX
male sex reversal (Bishop et al., 2000; Vidal et al., 2001). How-
ever, these examples of sex reversal, together with numerous
others in different mammalian species, occur as a result of an
altered cell fate decision of the common supporting cell lineage
precursor during development. They do not address the ques-
tion whether ‘terminally’ differentiated Sertoli or granulosa cells
can switch or flip-flop from one fate to that of the other as sug-
gested by Burgoyne et al. (1988). The demonstration here that
upon loss of Foxl2 mature granulosa/theca cells undergo trans-
differentiation into Sertoli/Leydig-like cells with high levels of
testosterone production is one of the few documented examples
of in vivo lineage reprogramming in an adult organism (Zhou and
Melton, 2008).
FOXL2 and SOX9: Yin and Yang of Sex Maintenance
Like Yin and Yang, FOXL2 and SOX9 oppose each other’s action
to ensure together the establishment and maintenance of the
different female and male supporting cell types respectively
(Figure 7). The observed upregulation of Sox9 as well as its
testis-specific regulatory element TESCO upon loss of FOXL2
function in mature granulosa cells not only demonstrates that
FOXL2 represses Sox9 expression but also begs the question
as to the identity of the positive factors required for Sox9 upregu-
lation in the absence of SRY? These could include extrinsic
factors known to be involved in positive feedback loops in the
early testis, such as FGF9, PGD2 or related family members,
which by themselves are each capable of stimulating high levels
of SOX9 in the early embryonic gonad in culture, or it could
involve intrinsic factors able to mimic SOX9 (Sekido and
Lovell-Badge, 2009). As Sox9 and Foxl2 are also expressed in
a mutually exclusive way in the gonads of many lower vertebrate
species, the suggested trans-repression between the two
factors seems to be an evolutionary conserved mechanism
(Barrionuevo et al., 2006; Chaboissier et al., 2004; Uhlenhaut
and Treier, 2006). It is therefore tempting to speculate that this
mechanism is central to the maintenance of the gonadal sexual
phenotype in vertebrates and supports the model in which the
decisive issue that determines the outcome of mammalian sex
development and maintenance is whether SOX9 can establish
an auto-regulatory self-maintaining loop or not (Kim et al.,
2006; Sekido and Lovell-Badge, 2008). Although Foxl2 is upre-
gulated in Sox9-conditional null mutant XY gonads (Barrionuevo
et al., 2006), direct repression of Foxl2 expression by SOX9
remains to be demonstrated.
As shown here, the maintenance of female gonadal sex
requires continuous expression of FOXL2 to suppress male
development. Due to the infertility of human females heterozy-
gous for FOXL2 mutations, the homozygous loss-of-function
phenotype has not yet been reported. In the mouse global
Foxl2 deletion, such as a null deletion (Foxl2/) or replacement
with lacZ (Foxl2lacZ/lacZ) leads to ovary dysgenesis but not to sex
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Figure 7. Model of Sox9 Regulation Required for Maintenance of
Gonadal Phenotype in Mammals
During initial phases of sex determination, SRY upregulates Sox9 expression,
and subsequent positive autoregulatory loops involving SOX9 itself, together
with FGF9 and prostaglandin D2 signaling, activate andmaintain Sox9 expres-
sion in male gonads, whereas b-catenin stabilized by WNT4 and RSPO1
signaling suppresses Sox9 expression in female gonads. After birth b-catenin
activity declines and thus in adult female gonads, FOXL2 and estrogen recep-
tors (ESR1/2) are required to actively repress Sox9 expression to ensure
ovarian somatic cell fate. The transcriptional repression of Sox9 by FOXL2
and estrogen receptors is necessary throughout the lifetime of the female to
prevent transdifferentiation of the somatic compartment of the ovary into
a testis (PTGDS, prostaglandin D synthase).reversal (gonadal or otherwise) during development in contrast
to the deletion at adult stages reported here (Schmidt et al.,
2004; Uda et al., 2004). Due to the observed upregulation of
SOX9 during perinatal stages in Foxl2/ ovaries, it was sug-
gested that granulosa cells have transdifferentiated into Ser-
toli-like cells (Ottolenghi et al., 2005). However, our comparison
of genomewide gene expression profiles revealed that postnatal
Foxl2 null mutant XX gonads do not show upregulation of most
of the 200 testis-specific genes observed in the conditional
mutant, such as Rhox8, Sox8, Ncoa2/TIF2, Tsx and Insl3, sug-
gesting that despite expression of SOX9 they have not transdif-
ferentated into bonafide Sertoli-like cells (Figures S7 and S8).
Importantly, we find that R-Spondin1 (Rspo1), which is still
robustly expressed in P3 wild-type ovaries, is more than 2-fold
upregulated in Foxl2 null mutant ovaries (Chassot et al.,
2008a). In contrast, Rspo1 is no longer significantly expressed
in adult ovaries nor is it upregulated in the conditional mutant
(Figure S8).
The WNT Pathway and FOXL2 Act Independently during
Gonadal Development
Mutations inR-Spondin1 lead to female-to-male sex reversal in at
least some humans and partially in mice, as does the global
disruption of murine Wnt4. This has led to the realization that
the WNT/b-catenin pathway is important for development of
the female gonad (Chassot et al., 2008b; Maatouk et al., 2008;
Parma et al., 2006; Tomizuka et al., 2008; Vainio et al., 1999). In
all these cases Foxl2 is still expressed, suggesting that Foxl2
is not regulated by WNT signaling and acts independently to
regulate SOX9 activity. We speculate that defined temporal
developmental windows of Rspo1 expression are essential to
allow the mutually exclusive expression of Sox9 and Foxl2 and
its deregulation may explain in part the variable outcome of
Foxl2 deletion seen in different species (Figure 7). This also
argues the independence of the two ‘‘anti-testis’’ pathways rep-
resented by FOXL2 and R-Spondin1/b-catenin and that (as
a minimum) both need to be lost to allow robust differentiation
of testicular cell types. In contrast to a previous report we do
not find a synergistic interaction between Wnt4 and Foxl2 (Otto-
lenghi et al., 2007)(Figure S9), and in accordance with the
observed upregulation of Rspo1 in Foxl2 null mutants these
data further suggest that negative regulation of SOX9 activity
through the WNT pathway is epistatic and dominant over
FOXL2activity duringXXgonadal development at least until birth.
The Steroid Connection: Interaction of FOXL2 and ESR1
In contrast to eutherian mammals, other vertebrate species,
even those employing genetic based sex determination mecha-
nisms, are sensitive to the application of exogenous hormones
(Barske and Capel, 2008; Guiguen et al., 2009; Shoemaker and
Crews, 2009). In particular estrogens have long been known to
be important for ovarian differentiation and they are able to
trigger male to female sex reversal in fish, reptiles and birds,
whereas decreasing estrogen levels in these species has the
opposing effect resulting in phenotypic males from females
(Guiguen et al., 2009; Nakamura, 2009). Exogenous estrogens
can even trigger XY ovary development in marsupials (Coveney
et al., 2001). The molecular mechanisms underlying theseCell 139, 1130–1142, December 11, 2009 ª2009 Elsevier Inc. 1139
phenomena are far from being understood. The demonstration
that FOXL2 and estrogen receptor interact in controlling granu-
losa cell identity at least in part through repression of Sox9
expression suggest that similar mechanisms operate in lower
vertebrate species, as Foxl2 is one of the few conserved ovarian
differentiation genes (Uhlenhaut and Treier, 2006). Furthermore it
validates in vivo the proposed importance of forkhead factors for
estrogen receptor function (Carroll et al., 2005).
While this early dependence on estrogens for ovary differenti-
ation is not evident in most eutherian mammals, this may not
be true of all. In contrast to the mouse, where there is no
ovarian steroidogenesis during fetal development, ruminants
such as the goat show precocious production of estrogens
from the earliest stages of ovary development. This is evident
from the onset of expression of CYP19a1. Pannetier et al.
(2006) have shown that Cyp19a1 is regulated by FOXL2 in the
fetal goat ovary, as we show here for adult mice (Figure 1B).
Therefore, in animals with PIS, estrogens will be absent in
addition to FOXL2 from early stages. As the PIS phenotype is
evident much earlier than in Foxl2 null mutant XX mice, this
suggests that estrogen activity may have replaced the RSPO1/
WNT/b-catenin pathway as the predominant anti-testis or
ovary differentiation mechanism during fetal development in
goats. Our results therefore strongly suggest that FOXL2 defi-
ciency is the sole underlying cause of female-to-male sex
reversal seen in the goat polled intersex syndrome (Pailhoux
et al., 2001).
ESR1/2 null mutant mice show a phenotype similar to that of
the Foxl2 conditional mutation, with post-pubertal appearance
of Sertoli-like cells and testis-tubule like structures in ovaries
(Couse et al., 1999). The origin of the Sertoli-like cells was not
resolved, indeed it was attributed to the loss of oocytes, which
we show here is more likely to be a consequence of Sertoli cell
differentiation than a cause. Thus our demonstration that ‘termi-
nally’ differentiated somatic ovarian cell types can cell autono-
mously switch their fate not only extends our understanding of
howmammalian sex is maintained but also reveals the presence
in mammals of an evolutionary conserved mechanism of verte-
brate sex determination.
FOXL2, SOX9, DMRT1, DAX1, and CYP19a1:
Who Depends on Whom?
Although we have demonstrated that FOXL2 regulates Sox9
expression, many of the other suggested interactions within
the proposed transcriptional network underlying sex determina-
tion/maintenance are mainly based on temporal gene expres-
sion patterns and have not been rigorously tested. DMRT1 is
required for postnatal testis differentiation in mice and its homo-
logs have been shown or suggested to be master sex-deter-
mining genes in the chicken and in some medaka species
(Guiguen et al., 2009; Raymond et al., 2000; Smith et al.,
2009). The observation that one of the strongest upregulated
genes in the ovary upon Foxl2 deletion is Dmrt1, and that
FOXL2 and DMRT1 appear to exhibit opposing effects on the
regulation of estrogen production in fish, suggests that FOXL2
(together with estrogen receptor) may directly repress Dmrt1
transcription. Similarly, upregulation of Dax1, an established
negative regulator of SF1, upon conditional Foxl2 deletion in1140 Cell 139, 1130–1142, December 11, 2009 ª2009 Elsevier Inc.the ovary may be due to derepression mechanisms. Alterna-
tively, activation of these two genesmay result from upregulation
of SOX9. The temporal appearance of SOX9 andDMRT1 in gran-
ulosa cells upon Foxl2 deletion supports the latter suggestion
(Figure S10). A similar unresolved matter is the transcriptional
regulation of Cyp19a1, the strongest downregulated gene
upon conditional Foxl2 deletion, in which FOXL2 and DMRT1
have been implicated (Figure 1B) (Guiguen et al., 2009). The
establishment of the inducible system of somatic ovarian reprog-
ramming presented here will now allow the definite clarification
of the transcriptional interaction network underlying the mainte-
nance of mammalian gonadal sex.
In conclusion, we show that the mammalian ovarian pheno-
type has to be maintained throughout adulthood, mainly by
active repression of the Sertoli cell-promoting gene Sox9,
and that FOXL2 (acting together with estrogen receptors) is
the critical factor responsible for this. The realization that
granulosa/theca cells in the adult ovary retain the plasticity
to transdifferentiate into long-lived Sertoli/Leydig cells with
subsequent testosterone production also has important implica-
tions for reproductive biology, in particular the treatment of
sex differentiation disorders in children, as well as premature
ovarian failure and female menopause, both of which are associ-
ated with declining estrogen levels and occasional signs of
masculinization.
EXPERIMENTAL PROCEDURES
Mouse Strains
All mouse strains used are described in Supplemental Experimental Proce-
dures.
Histochemistry
In situ hybrydisation was perfodrmed on 20 mm cryosections as described in
Supplemental Experimental Procedures. For immunohistochemistry, 20 mm
cryosections of 2% paraformaldehyde fixed ovaries were used (Leica
3050S). Sections were incubated in blocking solution (PBS containing 0.4%
Triton-X, 5%) for 1 hr at room temperature followed by overnight incubation
with the primary antibodies at 4C. The sections were washed (0.4% Triton-
X in PBS) and incubated for 1 hr at room temperature with the secondary
antibodies. FOXL2 was detected with a rabbit antibody described in Schmidt
et al. (2004) diluted 1:100. SOX9 was detected using an antibody described in
Stolt et al. (2003) diluted 1:200. ECFP was detected using an a-GFP antibody
(Torrey Pines Biolabs) diluted 1:500. DMRT1 was detected using an antibody
described in Raymond et al. (2000) diluted 1:2000.
Serum Testosterone Measurements
Venous blood was collected from the orbital sinus of mice. Serum was frozen
at 20C until assayed. Serum testosterone levels were measured by RIA in
collaboration with Dr. A. F. Parlow at the National Hormone and Peptide
Program, HUMC.
Protein Coimmunoprecipitation
HEK293 cells were transfected with expression vectors formurine Flag-tagged
FOXL2 and V5-tagged ESR1, ESR2, or Glucocorticoid Receptor (GR) cDNAs
using Fugene (Roche). After 48 hr, Co-IPs were performed by incubating
cleared cell lysates in the presence of Flag M2 beads (Sigma) overnight at
4C, followed by washing and standard Western blotting using either anti-
V5-HRP or anti-Flag-HRP antibodies. The nuclear receptor cDNAs were
a generous gift from J. Jonker (Salk Institute).
Diphtheria Toxin Oocyte Ablation Experiment
Diphtheria toxin (DT) (List Biological Laboratories, Campbell, CA) was dis-
solved in PBS and 8-week old female mice were injected three times i.m
with a 48 hr gap between each injection (50 mg/kg). Mice were killed and
ovaries dissected for analysis 9 days after the first injection.
Statistical Analysis
Values are given as the means ± SEM. Data were analyzed by Student’s t test.
Statistically significant threshold was accepted as p < 0.05.
ACCESSION NUMBERS
The genome-wide profiling data discussed in this publication have been
deposited in the NCBI GEO repository, accession number GSE16853.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, Supple-
mental References, two tables, ten figures, and a video summary and can
be found with this article online at http://www.cell.com/supplemental/
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